These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 14054844)

  • 1. [ADVANTAGES AND DISADVANTAGES OF BROMSULPHALEIN (BSP) RETENTION TESTS].
    TICHY J
    Cesk Gastroenterol Vyz; 1963 Apr; 17():168-74. PubMed ID: 14054844
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bromsulphalein test (BSP): test results in various liver diseases].
    Ito K; Nakagawa J; Minakuchi C; Tamai Y; Sano M
    Nihon Rinsho; 1969 Mar; ():Suppl:844-52. PubMed ID: 4948299
    [No Abstract]   [Full Text] [Related]  

  • 3. [The BSP purification tests].
    Chevrel B
    Presse Med (1893); 1969 Apr; 77(18):682. PubMed ID: 5790092
    [No Abstract]   [Full Text] [Related]  

  • 4. [The double retention test BSP (bromsulphalein)].
    Tichý JA
    Vnitr Lek; 1970 Feb; 16(2):146-9. PubMed ID: 4907669
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatic and renal elimation of bromsulphalein in chronic hepatitis, post-inflammatory cirrhosis and obstructive jaundice].
    Babiuch L
    Przegl Epidemiol; 1975; 29(2):159-67. PubMed ID: 1144806
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE KINETICS OF BROMSULPHALEIN. QUANTITATIVE DETERMINATION OF LIVER FUNCTION AND CHOLESTASIS].
    TURA S; PIERAGNOLI E; DALMONTE PR; CAMPANACCI D
    Minerva Med; 1963 Aug; 54():2393-9. PubMed ID: 14056611
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE VALUE OF FRACTIONAL CLEARANCE OF BSP IN THE DIAGNOSIS OF CHRONIC HEPATOPATHIES].
    NICOLAESCU T; FELBERG B; RUSOVICI L
    Med Interna (Bucur); 1964 Aug; 16():959-67. PubMed ID: 14192603
    [No Abstract]   [Full Text] [Related]  

  • 8. STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. I. IN NORMAL SUBJECTS AND PATIENTS WITH HEPATIC DISEASE.
    SCHOENFIELD LJ; FOULK WT; BUTT HR
    J Clin Invest; 1964 Jul; 43(7):1409-18. PubMed ID: 14192521
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of ICG and BSP elimination through the liver at different dosages].
    Jaross W; Schentke KU; Richter B; Tschöpel L; Renger F
    Z Gesamte Inn Med; 1970 Sep; 25(18):834-40. PubMed ID: 5522140
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the bromsulphalein test in chronic hepatitis and liver cirrhosis].
    Zherebtsov LA; Sharova IuA; Zamchiĭ AA
    Klin Med (Mosk); 1970 Jun; 48(6):52-8. PubMed ID: 5523985
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatic activity of glutathione transferase and bromsulphalein metabolism].
    Serra MA; Caballero A; Aparisi L; Rodrigo JM; Del Olmo JA; Ferrando J; Wassel AH; Reig G; Bixquert M
    Rev Esp Enferm Dig; 1991 Feb; 79(2):112-6. PubMed ID: 2059513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interpretation of bromsulphalein (BSP) value in liver diseases--with special reference to the analytical result of BSP metabolism].
    Ito K; Nakagawa J; Nakano H; Tamai Y; Maeda K
    Nihon Rinsho; 1967 Aug; 25(8):1917-25. PubMed ID: 5627398
    [No Abstract]   [Full Text] [Related]  

  • 13. [HEPATIC EXPLORATION BY INDOCYANINE GREEN. COMPARISON WITH BROMSULPHALEIN].
    BARBIER F; DEWEERDT GA
    Acta Gastroenterol Belg; 1964 Mar; 27():153-62. PubMed ID: 14167130
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulfobromophthalein (BSP) metabolism in viral hepatitis, liver cirrhosis and hereditarv spherocvtosis.
    HOENIG V; JIRSA M; HOENIGOVA J
    Acta Hepatosplenol; 1961 Aug; 8():217-26. PubMed ID: 13714916
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies of the function of the liver in chronic impairment by observing the glucuronization of o-iodobenzoic acid I-131 and bromsulphalein (BSP) and rose bengal-I-131 tests].
    Martínek K; Dohnálek J; Eysselt M; Huvar A
    Vnitr Lek; 1968 Sep; 14(9):878-84. PubMed ID: 5688648
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clearance of bromsulphalein in chronic hepatitis. Anatomo-functional study in 104 cases].
    Testa R; Ciravegna G; Dodero M; Celle G
    Recenti Prog Med; 1978 Aug; 65(2):117-21. PubMed ID: 715300
    [No Abstract]   [Full Text] [Related]  

  • 17. The bromsulphalein and galactose tolerance tests in patients with various liver diseases. A comparative study.
    den Blaauwen DH; Thijs LG
    Acta Gastroenterol Belg; 1973; 36(7):345-75. PubMed ID: 4751674
    [No Abstract]   [Full Text] [Related]  

  • 18. [Differential diagnosis: liver cirrhosis or chronic hepatitis. Effect of chronic hepatitis and liver cirrhosis on the retention of bromsulphalein in the blood serum].
    Vido I; Wildhirt E
    Munch Med Wochenschr; 1969 Jan; 111(4):177-80. PubMed ID: 5818553
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the liver function with the aid of bromsulphalein and vofaverdin].
    Geller LI; Bulgakova OS; Griaznova MV; Ozherel'eva NIa
    Vrach Delo; 1978 Jun; (6):78-81. PubMed ID: 695480
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bromsulphalein liver function test in horses. I. Direct determination of dye retention].
    Sova Z; Komárek J
    Zentralbl Veterinarmed A; 1965 Jul; 11(5):448-60. PubMed ID: 4954673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.